161 related articles for article (PubMed ID: 33285035)
1. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data.
Rosenberg CA; Rodrigues MA; Bill M; Ludvigsen M
Sci Rep; 2024 Apr; 14(1):9349. PubMed ID: 38654058
[TBL] [Abstract][Full Text] [Related]
3. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
[TBL] [Abstract][Full Text] [Related]
5. Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro.
Han SY; Lee EM; Kim S; Kwon AM; Baek EJ
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992584
[TBL] [Abstract][Full Text] [Related]
6. EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome.
Dong XM; Zhao K; Zheng WW; Xu CW; Zhang MJ; Yin RH; Gao R; Tang LJ; Liu JF; Chen H; Zhan YQ; Yu M; Ge CH; Gao HY; Li X; Luo T; Ning HM; Yang XM; Li CY
FASEB J; 2020 Jun; 34(6):8416-8427. PubMed ID: 32350948
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
[TBL] [Abstract][Full Text] [Related]
8. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
[TBL] [Abstract][Full Text] [Related]
9. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
[TBL] [Abstract][Full Text] [Related]
11. [Study on the implications of erythroblasts periodic acid-Schiff stain in myelodysplastic syndromes].
Liu L; Cui W; Zhang HL; Xu ZF; Zhang FK; Zheng YZ; Zhang Y; Qin TJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):259-64. PubMed ID: 21569710
[TBL] [Abstract][Full Text] [Related]
12. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
[TBL] [Abstract][Full Text] [Related]
13. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
[TBL] [Abstract][Full Text] [Related]
14. PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.
Aoyama K; Shinoda D; Suzuki E; Nakajima-Takagi Y; Oshima M; Koide S; Rizq O; Si S; Tara S; Sashida G; Iwama A
Leukemia; 2021 Apr; 35(4):1156-1165. PubMed ID: 32820269
[TBL] [Abstract][Full Text] [Related]
15. CD43 and CD49d from the B-Cell Chronic Lymphoproliferative Disorders Diagnostic Panel Are Useful to Detect Erythroid Dysplasia.
Oliveira M; Laranjeira P; Fortuna M; Bártolo R; Ribeiro A; Santos M; Cortesão E; Marques G; Sarmento-Ribeiro AB; Vitória H; Ribeiro L; Paiva A
Cytometry B Clin Cytom; 2019 Sep; 96(5):417-425. PubMed ID: 31157955
[TBL] [Abstract][Full Text] [Related]
16. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
Shameli A; Dharmani-Khan P; Luider J; Auer I; Shabani-Rad MT
Cytometry B Clin Cytom; 2021 Sep; 100(5):574-589. PubMed ID: 33369070
[TBL] [Abstract][Full Text] [Related]
17. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
[TBL] [Abstract][Full Text] [Related]
19. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
[TBL] [Abstract][Full Text] [Related]
20. Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes.
Zaninoni A; Imperiali FG; Cattaneo A; Soverini G; Binda F; Porretti L; Cortelezzi A; Barcellini W
Transfusion; 2016 Aug; 56(8):2037-41. PubMed ID: 27232106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
